CURRENT VIEWS ON PREDICTORS AND BIOMARKERS OF EARLY DIAGNOSIS OF ANTHRACYCLINE-MEDIATED CARDIOTOXICITY IN PATIENTS WITH BREAST CANCER (REVIEW OF LITERATURE)
Open Access
- 15 March 2020
- journal article
- abstracts
- Published by EKOlab in Russian Clinical Laboratory Diagnostics
- Vol. 65 (3) , 141-148
Abstract
Anthracyclines are effectively used in many therapeutic regimens for breast cancer (BC). However, the dose-dependent cardiotoxic effect causes certain limitations on their use. Laboratory tests for risk prediction and early diagnosis of anthracycline-induced cardiotoxicity (ACIC) based on measuring the activity and concentration of topoisomerase 2β, the levels of troponins T and I (TnT и TnI), N-terminal fragment of brain natriuretic peptide progenitor, remain relevant, but complicate the risk stratification with low specificity. Recently, the number of works devoted to the study of new biomarkers ACIC has been growing: galectin-3, soluble ST-2 (sST-2), and myeloperoxidase (MPO). In this review we analyzed current understanding of the classical markers ACIC and the results of recent studies dedicated to new predictors.Keywords
This publication has 19 references indexed in Scilit:
- Galectins as Molecular Targets for Therapeutic InterventionInternational Journal of Molecular Sciences, 2018
- Prevalence of anthracycline‐related cardiac dysfunction in long‐term survivors of adult‐onset lymphomaCancer, 2017
- A clinical importance of natriuretic peptides in pediatric practicePatologiya krovoobrashcheniya i kardiokhirurgiya, 2017
- Cardiotoxicity as indicated by LVEF and troponin T sensitivity following two anthracycline-based regimens in lymphoma: Results from a randomized prospective clinical trialOncotarget, 2016
- Cardiotoxicity of chemotherapyRussian Heart Journal, 2016
- GALECTIN-3 — BIOMARKER OF FIBROSIS IN PATIENTS WITH METABOLIC SYNDROMERussian Journal of Cardiology, 2015
- Serum biomarkers evaluation to predict chemotherapy-induced cardiotoxicity in breast cancer patientsTumor Biology, 2015
- Dexrazoxane may prevent doxorubicin-induced DNA damage via depleting both Topoisomerase II isoformsBMC Cancer, 2014
- Pathophysiological Roles and Clinical Importance of Biomarkers in Acute Coronary Syndrome2013
- Prognostic Value of Troponin I in Cardiac Risk Stratification of Cancer Patients Undergoing High-Dose ChemotherapyCirculation, 2004